Eun-ju Lee is a Hematologist in New York, New York. Dr. Lee is rated as an Elite provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Splenectomy.

James Bussel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Bussel is rated as an Elite provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Anemia, Hemolysis, and Splenectomy.

Nicole Lamanna is an Oncologist and a Hematologist in New York, New York. Dr. Lamanna is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy.

Joachim Fuks is an Oncologist in Bronx, New York. Dr. Fuks is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Malabsorption, Classical Hodgkin Lymphoma, Thrombocytopenia, and Hodgkin Lymphoma.

Dr. Henny Billett has been Chief of the Division of Hematology since 2012 and Professor of Clinical Medicine and Pathology since 2002. Dr. Billett is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Mesenteric Venous Thrombosis, Antiphospholipid Syndrome, Sickle Cell Disease, Venous Thromboembolism (VTE), and Splenectomy.

Dr. Mark Chaitowitz obtained his medical degree at the University of Witwatersrand in Johannesburg, South Africa. He relocated to the United States in 2001, where he completed his residency in internal medicine at Albert Einstein Medical Center, and fellowship in hematology and oncology at Thomas Jefferson University Hospital, both in Philadelphia. Dr. Chaitowitz is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Dr. Irina Murakhovskaya is an Assistant Professor of Medicine (Hematology). She completed a medical degree at Albert Einstein College of Medicine and residency and fellowship training at Montefiore Health System. Her clinical interests focus on monoclonal gammopathy, low-grade lymphoma, and hematologic issues in pregnancy. Dr. Murakhovskaya is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Autoimmune Hemolytic Anemia, Thrombocytopenia, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Amy Sharma , MD, is Co-Director, Hematology Oncology Fellowship Program and Assistant Professor, Hematology Oncology at Montefiore Einstein. Dr. Sharma maintains an active practice focusing on the treatment of sickle cell disease and classical hematology. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Non-Hodgkin Lymphoma, Myelofibrosis, Essential Thrombocythemia, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

Dr. Ellen Friedman’s passion is the study of the blood (hematology) and ensuring that the next generation of medical practitioners are prepared to analyze and treat blood-related problems. Dr. Friedman is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Thrombocytopenia, Acute Intermittent Porphyria, Essential Thrombocythemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Swati Goel, MBBS, is Leader of the Myeloproliferative Disorder Clinic, Assistant Director of the Hematology-Oncology Fellowship Program and Associate Professor in the Department of Oncology and Medicine at Montefiore Einstein. Her area of clinical focus is myeloproliferative neoplasms, and the conditions she treats include myelofibrosis, polycythemia vera, essential thrombocythemia, mastocytosis, eosinophilia, anemia and pancytopenia. Dr. Goel is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Myelofibrosis, Multicentric Castleman Disease (MCD), Castleman Disease, and Unicentric Castleman Disease (UCD).

Fernando J. Camacho, MD, is Assistant Professor, Oncology & Hematology at Montefiore Einstein. He has over 30 years of experience in community oncology and is the former Director of Community Oncology at Montefiore Einstein Center for Cancer Care. This program was established to increase access to preventative and cutting-edge cancer care and research to Bronx and Westchester patients and families and enhance visibility of the Center for Cancer Care through education, outreach and community engagement. Dr. Camacho is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Unicentric Castleman Disease (UCD), Castleman Disease, Multicentric Castleman Disease (MCD), and Chronic Lymphocytic Leukemia (CLL).

Daniel T. Friedman, MD, is Director, Community Hematology/Oncology at Montefiore Einstein and Assistant Professor, Medical Oncology at our Albert Einstein College of Medicine. He delivers community-focused care for hematology and medical oncology patients in the Bronx and Yonkers. Dr. Friedman is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Acquired Agranulocytosis, Myelodysplastic Syndrome (MDS), Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Endoscopy.

Dominder Kaur is a Pediatrics provider in Bronx, New York. Dr. Kaur is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Renal Vein Thrombosis, Sickle Cell Disease, Infantile Neutropenia, and Febrile Neutropenia.

Alice Lee, MD, is Director, Early Phase Clinical Trials program and Director, Pediatric Sarcoma program at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Lee’s clinical focus is on the treatment of children and young adults with sarcomas. She also has special interest in novel treatments for children with relapsed or refractory cancers. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Intersex and Immune Thrombocytopenic Purpura (ITP).

Alissa Baker, MD, is an Instructor in Pediatric Hematology/Oncology at Albert Einstein College of Medicine. Her clinical focus is in pediatric sarcomas with an interest in identifying biomarkers of metastases, as well as identifying new adjuvant therapies for this high-risk patient population. Dr. Baker joined the Montefiore team in 2018. Dr. Baker received her Doctor of Medicine from Penn State College of Medicine. She completed her residency in Pediatrics at Yale-New Haven Hospital, where she led the Quality Improvement team for the Pediatric Hematology/Oncology unit. Following residency, she completed her fellowship in Pediatric Hematology/Oncology at Johns Hopkins Hospital and The National Institutes of Health. Dr. Baker’s research focuses on Ewing sarcoma metastasis biology, with a specialized focus on Wnt signaling, using zebrafish as a model of sarcoma metastasis for high throughput drug screens to identify new agents, screening patient plasma and tissue samples for biomarkers of potential metastasis, and identifying circulating tumor cells in the blood of sarcoma patients as a possible correlative to disease burden. Her publications include a co-first author sentinel nature paper on mutation profiling in human cancer and a recent paper on the effects of Wnt signaling inhibition in Ewing sarcoma. In 2017, Dr. Baker received the Pearl M. Stetler Grant for Women Physicians. In 2018, she received the Paul Calabresi K12 Award in Clinical Oncology for her research in Ewing sarcoma biology. Dr. Baker is board certified and an active member of the American Academy of Pediatrics. In addition, she is a member of the American Association for Cancer Research and the National Pediatric Cancer Foundation. . Her top area of expertise is Immune Thrombocytopenic Purpura (ITP).

Allison M. Martin, MD, is an attending physician at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics, Microbiology and Immunology at our Albert Einstein College of Medicine. Dr. Martin’s clinical focus centers on pediatric brain and spinal cord tumors. . Her top areas of expertise are Medulloblastoma, Neurofibromatosis Type 1 (NF1), and Immune Thrombocytopenic Purpura (ITP).

Lisa Gennarini, MD, has been an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology and Blood & Marrow Cell Transplantation at Children's Hospital at Montefiore (CHAM) since 2014. Her clinical focus is on treatment of children with leukemia and lymphoma as well as various vascular anomalies. She is also the CHAM Principal Investigator for Children?s Oncology Group trials, and also leads the CHAM Vascular Malformations Program. Dr. Gennarini graduated from Siena College in 2004, earning her Bachelor of Science in Biology. In 2008, she received her Doctor of Medicine at State University of New York, Upstate Medical University in Syracuse. She began a residency in Pediatrics at Jefferson Medical College/A.I. duPont Hospital for Children, followed by a fellowship in Pediatric Hematology/Oncology at Children?s Hospital at Montefiore. Dr. Gennarini's work on pediatrics, topics ranging from sickle cell disease to implementing communications skills training courses in pediatric hematology/oncology, has been published in various journals and books, and presented nationally. Dr. Gennarini is board certified by the American Board of Pediatrics in Pediatric Hematology/Oncology and General Pediatrics. . Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Neuroblastoma, Bone Marrow Aspiration, and Adenoidectomy.

Megha Malhotra, MBBS, is an attending physician at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Malhotra’s clinical focus is on stem cell transplantation and cellular therapies for children with high-risk hematological malignancies, primarily acute lymphoblastic leukemia and acute myelogenous leukemia. She has a specific interest in alternative donors and stem cell graft modification for allogeneic transplants. . Her top areas of expertise are Infantile Neutropenia and Immune Thrombocytopenic Purpura (ITP).

Daniel A. Weiser, MD, is a board-certified pediatric hematologist/oncologist with clinical expertise in neuroblastoma and tumors of the adrenal glands, kidneys, liver, and gonads. He serves as Director of the Abdominal Solid Tumor Program and Co-Director of the Childhood Cancer Predisposition (CCP) Clinic at the Children’s Hospital at Montefiore Einstein. Dr. Weiser leads a highly specialized, multidisciplinary team dedicated to providing comprehensive and individualized care for children with a broad spectrum of solid tumors. . His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Adult Soft Tissue Sarcoma, and Osteosarcoma.

Dardan Demaliaj, MD, MPH, is an attending physician at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Demaliaj’s clinical focus centers on children and young adults with brain and spinal tumors. He is specifically interested in treating pediatric high-grade gliomas, expanding clinical trial offerings and utilizing personalized medicine to target patients’ tumors. . His top areas of expertise are Pediatric Low-Grade Glioma (pLGG) and Immune Thrombocytopenic Purpura (ITP).